|Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program|
WC Moore, DA Meyers, SE Wenzel, WG Teague, H Li, X Li, ...
American journal of respiratory and critical care medicine 181 (4), 315-323, 2010
|Treatment of asthma with drugs modifying the leukotriene pathway|
JM Drazen, E Israel, PM O'Byrne
New England Journal of Medicine 340 (3), 197-206, 1999
|Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program|
WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, ...
Journal of Allergy and Clinical Immunology 119 (2), 405-413, 2007
|Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations|
C Ober, DL Nicolae
Nature genetics 43 (9), 887-892, 2011
|Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial|
M Castro, AS Rubin, M Laviolette, J Fiterman, M De Andrade Lima, ...
American journal of respiratory and critical care medicine 181 (2), 116-124, 2010
|Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial|
E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ...
The Lancet 364 (9444), 1505-1512, 2004
|Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment|
JM Drazen, CN Yandava, L Dubé, N Szczerback, R Hippensteel, A Pillari, ...
Nature genetics 22 (2), 168-170, 1999
|Significant variability in response to inhaled corticosteroids for persistent asthma|
SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ...
Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002
|Tiotropium bromide step-up therapy for adults with uncontrolled asthma|
SP Peters, SJ Kunselman, N Icitovic, WC Moore, R Pascual, BT Ameredes, ...
New England Journal of Medicine 363 (18), 1715-1726, 2010
|The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma|
E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ...
American journal of respiratory and critical care medicine 162 (1), 75-80, 2000
|Interleukin-17–producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity|
HY Kim, HJ Lee, YJ Chang, M Pichavant, SA Shore, KA Fitzgerald, ...
Nature medicine 20 (1), 54-61, 2014
|Daily versus as-needed corticosteroids for mild persistent asthma|
HA Boushey, CA Sorkness, TS King, SD Sullivan, JV Fahy, SC Lazarus, ...
New England Journal of Medicine 352 (15), 1519-1528, 2005
|Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma|
SC Lazarus, VM Chinchilli, NJ Rollings, HA Boushey, R Cherniack, ...
American journal of respiratory and critical care medicine 175 (8), 783-790, 2007
|The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin|
E Israel, AR Fischer, MA Rosenberg, CM Lilly, JC Callery, J Shapiro, ...
American Review of Respiratory Disease 148 (6_pt_1), 1447-1451, 1993
|Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial|
SC Lazarus, HA Boushey, JV Fahy, VM Chinchilli, RF Lemanske Jr, ...
Jama 285 (20), 2583-2593, 2001
|Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma|
C Barnig, M Cernadas, S Dutile, X Liu, MA Perrella, S Kazani, ...
Science translational medicine 5 (174), 174ra26-174ra26, 2013
|The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air|
E Israel, R Dermarkarian, M Rosenberg, R Sperling, G Taylor, P Rubin, ...
New England Journal of Medicine 323 (25), 1740-1744, 1990
|Comparison of regularly scheduled with as-needed use of albuterol in mild asthma|
JM Drazen, E Israel, HA Boushey, VM Chinchilli, JV Fahy, JE Fish, ...
New England Journal of Medicine 335 (12), 841-847, 1996
|The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma|
E Israel, P Rubin, JP Kemp, J Grossman, W Pierson, SC Siegel, ...
Annals of internal medicine 119 (11), 1059-1066, 1993
|Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.|
KH In, K Asano, D Beier, J Grobholz, PW Finn, EK Silverman, ...
The Journal of clinical investigation 99 (5), 1130-1137, 1997